Imatinib as a possible cause of severe rhabdomyolysis
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 358, Issue 25, Pages 2746-2747Publisher
MASSACHUSETTS MEDICAL SOC
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Chlorpheniramine poisoning as a potential cause of rhabdomyolysis
Qingqing Guo, Hao Lin, Jiandong Lin
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2022)
FIP1L1-PDGFRA-Associated Hypereosinophilic Syndrome as a Treatable Cause of Watershed Infarction
Juliette Tennenbaum, Matthieu Groh, Laura Venditti, France Campos-Gazeau, Emilie Chalayer, Thomas De Broucker, Mohamed Hamidou, Mathilde Hunault, Aicha Lyoubi, Raphaelle Meunier, Thierry Muron, Damien Sene, Borhane Slama, Celine Guidoux, Guillaume Lefevre, Jean-Emmanuel Kahn, Christian Denier, Julien Rohmer
STROKE (2021)
Consensus definition of sludge and microlithiasis as a possible cause of pancreatitis
Michal Zorniak, Simon Sirtl, Georg Beyer, Ujjwal Mukund Mahajan, Katharina Bretthauer, Joerg Schirra, Christian Schulz, Thomas Kohlmann, Markus M. Lerch, Julia Mayerle, LMU Microlithiasis Expert Survey Team
GUT (2023)
A case of Legionnaires' disease with severe rhabdomyolysis misdiagnosed as COVID-19
Basak Sayinalp-Arslan, Ahmet Gorkem Er, Mehmet Yildirim, Banu Kilicaslan, Seda Banu Akinci, Omrum Uzun
HELIYON (2022)
Homozygous DBF4 mutation as a cause of severe congenital neutropenia
Mathijs Willemsen, John S. Barber, Erika Van Nieuwenhove, Frederik Staels, Margaux Gerbaux, Julika Neumann, Teresa Prezzemolo, Emanuela Pasciuto, Vasiliki Lagou, Nancy Boeckx, Jessica Filtjens, Amber De Visscher, Patrick Matthys, Rik Schrijvers, Thomas Tousseyn, Mark O'Driscoll, Giorgia Bucciol, Susan Schlenner, Isabelle Meyts, Stephanie Humblet-Baron, Adrian Liston
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)
Coronavirus Disease 2019 as a Possible Cause of Severe Orbital Cellulitis
Vinicius Almeida Carvalho, Vinicius Eduardo de Oliveira Verginio, Gabriel Conceicao Brito, Cecilia Luiz Pereira-Stabile, Glaykon Alex Vitti Stabile
JOURNAL OF CRANIOFACIAL SURGERY (2021)
TREM2 variants as a possible cause of frontotemporal dementia with distinct neuroimaging features
Bedia Samanci, Basar Bilgic, Ozlem Gelisin, Fatih Tepgec, Gamze Guven, Zeynep Tufekcioglu, Merve Alaylioglu, Hasmet A. Hanagasi, Hakan Gurvit, Rita Guerreiro, John Hardy, Murat Emre
EUROPEAN JOURNAL OF NEUROLOGY (2021)
Variants in DTNA cause a mild, dominantly inherited muscular dystrophy
Andres Nascimento, Christine C. Bruels, Sandra Donkervoort, A. Reghan Foley, Anna Codina, Jose C. Milisenda, Elicia A. Estrella, Chengcheng Li, Jordi Pijuan, Isabelle Draper, Ying Hu, Seth A. Stafki, Lynn S. Pais, Vijay S. Ganesh, Anne O'Donnell-Luria, Safoora B. Syeda, Laura Carrera-Garcia, Jessica Exposito-Escudero, Delia Yubero, Loreto Martorell, Iago Pinal-Fernandez, Hart G. W. Lidov, Andrew L. Mammen, Josep M. Grau-Junyent, Carlos Ortez, Francesc Palau, Partha S. Ghosh, Basil T. Darras, Cristina Jou, Louis M. Kunkel, Janet Hoenicka, Carsten G. Bonnemann, Peter B. Kang, Daniel Natera-de Benito
ACTA NEUROPATHOLOGICA (2023)
Bi-allelic loss-of-function OBSCN variants predispose individuals to severe recurrent rhabdomyolysis
Macarena Cabrera-Serrano, Laure Caccavelli, Marco Savarese, Anna Vihola, Manu Jokela, Mridul Johari, Thierry Capiod, Marine Madrange, Enrico Bugiardini, Stefen Brady, Rosaline Quinlivan, Ashirwad Merve, Renata Scalco, David Hilton-Jones, Henry Houlden, Halil Ibrahim Aydin, Serdar Ceylaner, Sarah Drewes, Jerry Vockley, Rhonda L. Taylor, Chiara Folland, Aasta Kelly, Hayley Goullee, Emil Ylikallio, Mari Auranen, Henna Tyynismaa, Bjarne Udd, Alistair R. R. Forrest, Mark R. Davis, Drago Bratkovic, Nicholas Manton, Thomas Robertson, Cullen O'Gorman, Pamela McCombe, Nigel G. Laing, Liza Phillips, Pascale de Lonlay, Gianina Ravenscroft
BRAIN (2022)
Aberrant expression of agouti signaling protein (ASIP) as a cause of monogenic severe childhood obesity
Elena Kempf, Kathrin Landgraf, Robert Stein, Martha Hanschkow, Anja Hilbert, Rami Abou Jamra, Paula Boczki, Gunda Herberth, Andreas Kuehnapfel, Yu-Hua Tseng, Claudia Staeubert, Torsten Schoeneberg, Peter Kuehnen, N. William Rayner, Eleftheria Zeggini, Wieland Kiess, Matthias Blueher, Antje Koerner
NATURE METABOLISM (2022)
Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report
Poumeaud Francois, Fontanier Anna, Dion Jeremie, Mathevet Quentin, Cointault Olivier, Uro-Coste Emmanuelle, Marty Celine, Dalenc Florence, Girardie Pierre, Rataboul Anais
FRONTIERS IN ONCOLOGY (2022)
Premature senescence of placental decidua cells as a possible cause of miscarriage produced by mycophenolic acid
Paz de la Torre, Miguel Fernandez-de la Torre, Ana I. Flores
JOURNAL OF BIOMEDICAL SCIENCE (2021)
Severe rhabdomyolysis induced by possible drug-drug interaction between Ribociclib and Simvastatin
Caroline Streicher, Annick Daulange, Nicolas Madranges, Laure Vayre
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2021)
De Novo Variant in the KCNJ9 Gene as a Possible Cause of Neonatal Seizures
Taisiya O. O. Kochetkova, Dmitry N. N. Maslennikov, Ekaterina R. R. Tolmacheva, Jekaterina Shubina, Anna S. S. Bolshakova, Dzhenneta I. I. Suvorova, Anna V. V. Degtyareva, Irina V. V. Orlovskaya, Maria V. V. Kuznetsova, Anastasia A. A. Rachkova, Gennady T. T. Sukhikh, Denis V. V. Rebrikov, Dmitriy Yu. Trofimov
GENES (2023)
Tobacco use as a well-recognized cause of severe COVID-19 manifestations
Alpana Kumar Gupta, Suzanne Tanya Nethan, Ravi Mehrotra
RESPIRATORY MEDICINE (2021)
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression
Cora N. Sternberg, Daniel P. Petrylak, Joaquim Bellmunt, Hiroyuki Nishiyama, Andrea Necchi, Howard Gurney, Jae-Lyun Lee, Michiel S. van der Heijden, Eli Rosenbaum, Nicolas Penel, See-Tong Pang, Jian-Ri Li, Xavier Garcia del Muro, Florence Joly, Zsuzsanna Papai, Weichao Bao, Peter Ellinghaus, Chengxing Lu, Mitchell Sierecki, Sabine Coppieters, Keiko Nakajima, Tatiane Cristine Ishida, David Quinn
JOURNAL OF CLINICAL ONCOLOGY (2023)
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022
Christian Rothermundt, Dimosthenis Andreou, Jean-Yves Blay, Thomas Brodowicz, Ingrid M. E. Desar, Palma Dileo, Hans Gelderblom, Rick Haas, Jens Jakob, Robin L. Jones, Ian Judson, Wolfgang G. Kunz, Berndadette Liegl-Atzwanger, Lars H. Lindner, Christina Messiou, Aisha B. Miah, Peter Reichardt, Joanna Szkandera, Winette T. A. van der Graaf, Winan J. van Houdt, Eva Wardelmann, Silvia Hofer
EUROPEAN JOURNAL OF CANCER (2023)
Quality of Sarcoma Care: Longitudinal Real-Time Assessment and Evidence Analytics of Quality Indicators
Philip Heesen, Gabriela Studer, Beata Bode, Hubi Windegger, Benjamin Staeheli, Paul Aliu, Javier Martin-Broto, Alessandro Gronchi, Jean-Yves Blay, Axel Le Cesne, Bruno Fuchs
CANCERS (2023)
Pain in desmoid-type fibromatosis: Prevalence, determinants and prognosis value
Nicolas Penel, Sylvie Bonvalot, Marie-Cecile Le Deley, Antoine Italiano, Camille Tlemsani, Diane Pannier, Clemence Leguillette, Jean-Emmanuel Kurtz, Maud Toulmonde, Julien Thery, Daniel Orbach, Pascale Dubray-Longeras, Benjamin Verret, Francois Bertucci, Cecile Guillemet, Lucie Laroche, Armelle Dufresne, Jean-Yves Blay, Axel Le Cesne
INTERNATIONAL JOURNAL OF CANCER (2023)
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial
Vivek Subbiah, Robert J. Kreitman, Zev A. Wainberg, Anas Gazzah, Ulrik Lassen, Alexander Stein, Patrick Y. Wen, Sascha Dietrich, Maja J. A. de Jonge, Jean-Yves Blay, Antoine Italiano, Kan Yonemori, Daniel C. Cho, Filip Y. F. L. de Vos, Philippe Moreau, Elena Elez Fernandez, Jan H. M. Schellens, Christoph C. Zielinski, Suman Redhu, Aislyn Boran, Vanessa Q. Passos, Palanichamy Ilankumaran, Yung-Jue Bang
NATURE MEDICINE (2023)
Efficacy and Safety of Adjuvant Radiotherapy in Re-excised Soft-tissue Sarcoma After Unplanned Resection
Benoit Allignet, Paul Pou, Floriane Izarn, Isabelle Ray-Coquard, Jean-Yves Blay, Armelle Dufresne, Mehdi Brahmi, Amine Bouhamama, Pierre Meeus, Gualter Vaz, Francois Gouin, Alexandra Meurgey, Marie Karanian, Coralie Moncharmont, Waisse Waissi, Marie-Pierre Sunyach
ONCOLOGIST (2023)
Why will there never be a randomized trial for NTRK-rearranged tumors?
N. Penel, L. Lebellec, J. -y. Blay
ANNALS OF ONCOLOGY (2023)
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study
Florence Duffaud, Jean-Yves Blay, Axel Le Cesne, Christine Chevreau, Pascaline Boudou-Rouquette, Elsa Kalbacher, Nicolas Penel, Christophe Perrin, Valerie Laurence, Emmanuelle Bompas, Esma Saada-Bouzid, Corinne Delcambre, Francois Bertucci, Mathilde Cancel, Camille Schiffler, Laure Monard, Corinne Bouvier, Vincent Vidal, Nathalie Gaspar, Sylvie Chabaud
BRITISH JOURNAL OF CANCER (2023)
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study1
Hans Gelderblom, Robin L. Jones, Jean-Yves Blay, Suzanne George, Margaret von Mehren, John R. Zalcberg, Yoon-Koo Kang, Albiruni Abdul Razak, Jonathan Trent, Steven Attia, Axel Le Cesne, Brittany L. Siontis, David Goldstein, Kjetil Boye, Cesar Sanchez, Neeltje Steeghs, Piotr Rutkowski, Mihaela Druta, Cesar Serrano, Neeta Somaiah, Ping Chi, Brooke Harrow, Claus Becker, William Reichmann, Matthew L. Sherman, Rodrigo Ruiz-Soto, Michael C. Heinrich, INTRIGUE Investigators
EUROPEAN JOURNAL OF CANCER (2023)
A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages
Iseulys Richert, Paul Berchard, Lhorra Abbes, Alexey Novikov, Kamel Chettab, Alexandra Vandermoeten, Charles Dumontet, Marie Karanian, Jerome Kerzerho, Martine Caroff, Jean-Yves Blay, Aurelie Dutour
CANCERS (2023)
Evolution of Patterns of Care and Outcomes in the Real-Life Setting for Patients with Metastatic GIST Treated in Three French Expert Centers over Three Decades
Maud Toulmonde, Derek Dinart, Mehdi Brahmi, Benjamin Verret, Myriam Jean-Denis, Francoise Ducimetiere, Gregoire Desolneux, Pierre Meeus, Jean Palussiere, Xavier Buy, Amine Bouhamama, Pauline Gillon, Armelle Dufresne, Clemence Henon, Francois Le Loarer, Marie Karanian, Carine Ngo, Simone Mathoulin-Pelissier, Carine Bellera, Axel Le Cesne, Jean Yves Blay, Antoine Italiano
CANCERS (2023)
Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort
Olivier Tredan, Maud Toulmonde, Christophe Le Tourneau, Laure Montane, Antoine Italiano, Isabelle Ray-Coquard, Christelle de la Fouchardiere, Francois Bertucci, Anthony Goncalves, Carlos Gomez-Roca, Benoit You, Valery Attignon, Sandrine Boyault, Philippe A. Cassier, Armelle Dufresne, Severine Tabone-Eglinger, Alain Viari, Emilie Sohier, Maud Kamal, Gwenael Garin, Jean-Yves Blay, David Perol
CANCERS (2023)
Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with Hot Tumor Immune Microenvironment
Xiaolan Feng, Laurie Tonon, Haocheng Li, Elodie Darbo, Erin Pleasance, Nicolas Macagno, Armelle Dufresne, Mehdi Brahmi, Julien Bollard, Francoise Ducimetiere, Marie Karanian, Alexandra Meurgey, Gaelle Perot, Thibaud Valentin, Frederic Chibon, Jean-Yves Blay
CANCERS (2023)
Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAFV600-mutated melanoma
J. Y. Blay, C. Cropet, S. Mansard, Y. Loriot, C. De La Fouchardiere, J. Haroche, D. Topart, D. Tougeron, B. You, A. Italiano, V. Le Brun-Ly, J. M. Ferrero, N. Penel, M. Fabbro, X. Troussard, D. Malka, I. Ray-Coquard, S. Leboulleux, A. Flechon, E. Maubec, J. Charles, S. Dalle, S. Taieb, G. C. T. E. Garcia, A. M. Mandache, N. Colignon, M. Gavrel, F. Nowak, N. Hoog Labouret, C. Mahier Ait Oukhatar, C. Gomez-Roca
ESMO OPEN (2023)